Family Planning Elevated: Initiative Evaluation

Sponsor
University of Utah (Other)
Overall Status
Recruiting
CT.gov ID
NCT03877757
Collaborator
(none)
22
1
52.8
0.4

Study Details

Study Description

Brief Summary

Family Planning Elevated (FPE) is a statewide contraceptive initiative with two primary aims:
  1. supporting existing and proposed legislative policy that expands family planning services in Utah among low-income individuals covered by contraceptive legislation (currently individuals at ≤100% federal poverty) and 2) demonstrating additional existing service need among low-income individuals who currently fall in the contraceptive coverage gap (101%-250% federal poverty). Family Planning Elevated provides contraceptive grants, education and training, and technical assistance on comprehensive contraceptive care to participating clinics. The purpose of this evaluation is to assess the effect of FPE on clinic-level family planning service delivery among 1) low-income women at ≤100% federal poverty, and 2) low-income women who fall in the contraceptive coverage gap (currently 101-250% federal poverty) compared to matched control clinics which did not receive the intervention. To assess these effects, FPE will collect monthly family planning service delivery data from both intervention and control clinics, beginning 12 months prior to the FPE intervention, and following for 12 months after the FPE intervention ends. A difference-in-difference analysis will compare trends and level-changes in family planning services provided to intervention and control groups.
Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Intervention clinics (FPE Contraceptive Access Program [FPE CAP]) receive a multifaceted contraceptive intervention, including:

    1. Training and technical assistance on contraceptive counseling and provision for FPE CAP providers, administrators, and health center support staff. FPE CAP staff will be required to attend an annual contraceptive training conference and receive additional remote and on-site technical support on counseling and provision of contraceptive methods. Methods include emergency contraception, oral contraceptive pills, contraceptive patch, vaginal ring, contraceptive injection, fertility awareness methods, condoms, contraceptive implant, hormonal IUDs, and non-hormonal IUD and other contraceptive methods, as feasible.

    2. FPE will provide FPE CAP members a cash grant to offset personnel and equipment costs associated with FPE CAP start-up and implementation.

    3. Monthly reimbursement for FPE CAP contraceptive services. As a result of the Medicaid Family Planning Waiver effective January 1, 2019, Utah health centers may claim Medicaid reimbursement for contraceptive services provided to Medicaid enrolled clients at ≤100% Federal Poverty Level. FPE CAP seeks to expand this coverage by providing reimbursement to FPE CAP health centers for contraceptive services provided to clients at 101% - 250% FPL (or 0% - 250% FPL for undocumented clients). Clients must be of reproductive age seeking female-user dependent methods and not be eligible for Medicaid/PCN.

    4. Contraceptive method stock. The high upfront cost of some contraceptive methods, particularly IUDs and implants, is often a barrier for health centers to maintain adequate contraceptive inventory. During the FPE CAP project period, members will be provided a stock of IUDs and implants to provide to eligible FPE CAP clients. Health centers will be also be reimbursed or provided vouchers for short-acting methods including oral contraceptive pills, vaginal rings, contraceptive injections, condoms, cycle beads, and emergency contraception. FPE will provide technical assistance to members to build a sustainable inventory of contraceptive methods for the post-FPE CAP project period. This will include training on drug forecasting and stocking, 340B Drug Discount Program, group purchasing organizations, and patient assistance programs.

    5. Evaluative Support: FPE CAP members will be responsible for providing routine data to FPE to help us assess the impact of the program. As part of this effort, FPE CAP members will receive evaluative support in developing and reporting data requirements both for the program and to fill existing clinical data needs around contraception. Additionally, data provided to the FPE team will be analyzed and returned back to the individual health centers as part of the dissemination strategy.

    6. Marketing campaign: FPE will produce a targeted media campaign to increase public awareness of expanded eligibility for contraceptive services, improve demand for contraceptive services at community health centers, and provide client education on available contraceptive options. FPE will support FPE CAP members by creating customized media campaigns for community outreach and education.

    Control clinics are similar clinics (matched by clinic size, geography, and serving Medicaid clients) who are not interested in participating in Family Planning Elevated, but are willing to provide the monthly service delivery data for the same time periods as their matched intervention clinic.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    22 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of the Family Planning Elevated Statewide Contraceptive Service Delivery Initiative
    Actual Study Start Date :
    Feb 1, 2019
    Anticipated Primary Completion Date :
    Jun 28, 2023
    Anticipated Study Completion Date :
    Jun 28, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Family Planning Elevated Contraceptive Access Clinics Program

    This group consists of community clinics who apply and are accepted for FPE CAP membership during the Family Planning Elevated initiative. These clinics will receive the intervention and will provide monthly service delivery data to the FPE evaluation team.

    Control Clinics

    This group consists of non-participating community clinics matched on clinic size, geography, and client populations who are not interested in participating in the initiative but are willing to provide monthly service delivery data to the FPE evaluation team.

    Outcome Measures

    Primary Outcome Measures

    1. Linear slope changes in total family planning services provided to women at ≤100% federal poverty level, as measured by monthly service delivery report [12 months prior to FPE intervention start, for the 24-month intervention period, and for 12 months post-intervention]

      Family planning services are defined as all family planning-related E/M, CPT, and HCPC codes within the FPE monthly service delivery report

    2. Linear slope changes in total family planning services provided to women between 101-250% federal poverty level, as measured by monthly service delivery report [12 months prior to FPE intervention start, for the 24-month intervention period, and for 12 months post-intervention]

      Family planning services are defined as all family planning-related E/M, CPT, and HCPC codes within the FPE monthly service delivery report

    Secondary Outcome Measures

    1. Linear slope changes in total long-acting reversible contraceptive services (LARC) provided to all women, as measured by monthly service delivery report [12 months prior to FPE intervention start, for the 24-month intervention period, and for 12 months post-intervention]

      Defined as all related E/M, CPT, and HCPC codes related to LARC methods within the FPE monthly service delivery report

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women of reproductive age (age 18-50) who visited the intervention or control clinic within the allotted time frame.
    Exclusion Criteria:
    • Under age 18

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Utah, Department of Obstetrics & Gynecology Salt Lake City Utah United States 84132

    Sponsors and Collaborators

    • University of Utah

    Investigators

    • Principal Investigator: Rebecca Simmons, PhD, University of Utah, Department of OBGYN

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Utah
    ClinicalTrials.gov Identifier:
    NCT03877757
    Other Study ID Numbers:
    • 117213
    First Posted:
    Mar 18, 2019
    Last Update Posted:
    Apr 28, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Utah

    Study Results

    No Results Posted as of Apr 28, 2022